Because children with AML and NUP98 or CBFA2T3 fusions treated with chemotherapy alone have poor relapse-free survival (de Rooij et al. 2016), both patients underwent a matched unrelated donor bone marrow transplant. The gene discussed is NUP98; the disease is acute myeloid leukemia.